(Q44193616)

English

The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states

scientific article published in November 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 November 2017

The effects of neuroleptic medications on basal ganglia blood flow in schizophreniform disorders: a comparison between the neuroleptic-naïve and medicated states (English)

1 reference

Europe PubMed Central

30 November 2017

object named as

Daniel S O'Leary

2

0 references

author name string

Patricia Westmoreland Corson

1

1 reference

Europe PubMed Central

30 November 2017

Del D Miller

3

1 reference

Europe PubMed Central

30 November 2017

Nancy C Andreasen

4

1 reference

Europe PubMed Central

30 November 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

30 November 2017

Biological Psychiatry

1 reference

Europe PubMed Central

30 November 2017

52

1 reference

Europe PubMed Central

30 November 2017

9

1 reference

Europe PubMed Central

30 November 2017

855-862

1 reference

Europe PubMed Central

30 November 2017

Correlational studies of the Scale for the Assessment of Negative Symptoms and the Scale for the Assessment of Positive Symptoms: an overview and update

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Image processing for the study of brain structure and function: problems and programs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Positron emission tomography studies of abnormal glucose metabolism in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Schizophrenia, psychosis, and the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Parkinsonism in neuroleptic-naive schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Neuroleptic treatment and caudate plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Left globus pallidus abnormality in never-medicated patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

The basal ganglia and cognitive pattern generators

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Regional Brain Function in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Improving tissue classification in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Changes in caudate volume with neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

THE NITROUS OXIDE METHOD FOR THE QUANTITATIVE DETERMINATION OF CEREBRAL BLOOD FLOW IN MAN: THEORY, PROCEDURE AND NORMAL VALUES.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Measurement of brain structures with artificial neural networks: two- and three-dimensional applications.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Positron emission tomography and subcortical glucose metabolism in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Dorsal striatal size, shape, and metabolic rate in never-medicated and previously medicated schizophrenics performing a verbal learning task

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

High-resolution SPECT study of regional cerebral blood flow in drug-free and drug-naive schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Brain metabolism in patients with schizophrenia before and after acute neuroleptic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Caudate size in first-episode neuroleptic-naive schizophrenic patients measured using an artificial neural network

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Hypofrontality in schizophrenia: a review of the evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2802%2901421-X

7 January 2021

Identifiers

10.1016/S0006-3223(02)01421-X

1 reference

Europe PubMed Central

30 November 2017

1 reference

Europe PubMed Central

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44193616&oldid=2108398944"